MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
837.34%
Quick Ratio
814.40%
Cash Ratio
298.09%
Debt to Asset Ratio
65.90%
Unit: Thousand (K) dollars
Assets Breakdown
    • Marketable securities
    • Cash and cash equivalents
    • Accounts receivable, net of allo...
    • Others
Liabilities Breakdown
    • Class a and class b common stock...
    • Accumulated deficit
    • Convertible debt, net of deferre...
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
258,604
125,391
164,086
98,897
Accounts receivable, net of allowance for credit loss of nil and nil
27,826
22,723
16,076
8,323
Inventory
19,901
15,844
11,411
5,710
Prepaid expenses and other current assets
13,861
15,972
11,536
8,925
Marketable securities
402,352
408,338
365,125
450,148
Interest receivable on marketable securities
3,888
3,261
3,285
5,527
Total current assets
726,432
591,529
571,519
577,530
Total property and equipment
-
-
1,748
-
Less accumulated depreciation and amortization
-
-
1,184
-
Property and equipment, net of accumulated depreciation of 1,331 and 1,184, respectively
715
535
564
560
Intangible assets, net of accumulated amortization of 2,777 and 1,856, respectively
10,292
10,755
11,214
11,680
Operating lease right-of-use assets
3,240
3,598
3,918
4,329
Other non-current assets
3,824
3,824
7,607
7,462
Total assets
744,503
610,241
594,822
601,561
Accounts payable
12,089
22,435
9,479
15,360
Current operating lease liabilities
1,715
1,838
1,880
1,871
Contract liabilities, current portion
8,855
8,651
7,515
6,721
Liability related to revenue interest financing agreement, current portion
12,999
7,944
9,585
5,982
Short-term borrowings
5,893
5,790
5,724
5,618
Warrant liability
0
0
2,865
1,738
Accrued expenses
45,204
32,864
45,183
32,579
Total current liabilities
86,755
79,522
82,231
68,131
Contract liabilities, net of current portion
8,228
9,743
11,305
11,130
Non-current operating lease liabilities
1,910
2,199
2,543
2,970
Non-current liability related to revenue interest financing agreement, net of deferred financing costs of 3,818 and 4,241, respectively
151,122
151,886
145,819
144,621
Long-term borrowings, net of deferred financing costs of 3,042
0
47,327
47,208
47,089
Convertible debt, net of deferred financing costs of 7,376
242,624
-
-
-
Total liabilities
490,639
290,677
289,106
275,679
Class a and class b common stock and additional paid in capital, 0.0001 par value per share 1,060,000,000 (class a 1,000,000,000, class b 60,000,000 shares authorized as of june 30, 2026 and december 31, 2025 respectively 349,822,479 (class a 348,822,479, class b 1,000,000) and 346,503,675 (class a 345,503,675, class b 1,00,000) shares issued and outstanding as of june 30, 2026 and december 31, 2025, respectively
1,429,288
1,431,214
1,421,273
1,404,799
Accumulated deficit
-1,172,813
-1,109,973
-1,115,370
-1,078,778
Accumulated other comprehensive loss
-2,611
-1,677
-187
-139
Total stockholders' equity
253,864
319,564
305,716
325,882
Total liabilities and stockholders' equity
744,503
610,241
594,822
601,561
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Marketable securities$402,352K (11.84%↑ Y/Y)Cash and cashequivalents$258,604K (4.29%↑ Y/Y)Accounts receivable, netof allowance for...$27,826K (933.27%↑ Y/Y)Inventory$19,901K (3505.25%↑ Y/Y)Prepaid expenses andother current assets$13,861K (67.87%↑ Y/Y)Interest receivable onmarketable securities$3,888K (-2.41%↓ Y/Y)Total current assets$726,432K (16.56%↑ Y/Y)Intangible assets, net ofaccumulated amortization of...$10,292K (-15.26%↓ Y/Y)Other non-currentassets$3,824K (-42.20%↓ Y/Y)Operating leaseright-of-use assets$3,240K (-30.19%↓ Y/Y)Property and equipment,net of accumulated...$715K (16.26%↑ Y/Y)Total assets$744,503K (15.03%↑ Y/Y)Total liabilities andstockholders' equity$744,503K (15.03%↑ Y/Y)Total liabilities$490,639K (78.86%↑ Y/Y)Total stockholders'equity$253,864K (-31.92%↓ Y/Y)Accumulated deficit-$1,172,813K (-14.65%↓ Y/Y)Accumulated othercomprehensive loss-$2,611K (-698.47%↓ Y/Y)Convertible debt, net ofdeferred financing costs...$242,624K Non-current liabilityrelated to revenue...$151,122K (5.84%↑ Y/Y)Total currentliabilities$86,755K (30.74%↑ Y/Y)Contract liabilities,net of current...$8,228K (-33.96%↓ Y/Y)Non-current operating leaseliabilities$1,910K (-43.81%↓ Y/Y)Class a and class bcommon stock and...$1,429,288K (2.37%↑ Y/Y)Accrued expenses$45,204K (88.37%↑ Y/Y)Liability related torevenue interest...$12,999K (360.47%↑ Y/Y)Accounts payable$12,089K (-46.08%↓ Y/Y)Contract liabilities,current portion$8,855K (-8.95%↓ Y/Y)Short-term borrowings$5,893K (5.55%↑ Y/Y)Current operating leaseliabilities$1,715K (-5.14%↓ Y/Y)
cropped-static1-svg

Nuvation Bio Inc. (NUVB)

cropped-static1-svg

Nuvation Bio Inc. (NUVB)